Prevention of type 1 diabetes from laboratory to public health

Autoimmunity

Volumn 29, Issue 3, 1999, Pages 235-246

  Flanders, Gretchen ^a   Graves, Patricia ^a   Rewers, Marian ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Beta cell autoimmunity; Clinical trials; Diabetes; Insulin; Nicotinamide; Screening

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; INSULIN; NICOTINAMIDE;

AUTOIMMUNITY; GENETIC SCREENING; HUMAN; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; PUBLIC HEALTH; REVIEW;

EID: 0032910991     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939908998537     Document Type: Review

References (91)

1. Rewers, M., Bugawan, T.L., Norris, J.M., Blair, A., Beaty, B., Hoffman, M. et al. Newborn screening for HLA markers associated with IDDM: Diabates Autoimmunity Study in the Young (DAISY). Diabetologia 1996; 39: 807-812.
2. Ilonen, J., Reijonen, H., Herva, E., Sjoroos, M., Iitia, N., Lovgren, T. et al. Rapid HLA-DQB1 Genotyping for Four Alleles in the Assessment of Risk for IDDM in the Finnish Population. Diabetes Care 1996; 19(8): 795-800.
3. Verge, C.F., Gianani, R., Kawasaki, B., Yu, L., Pietropaolo, M., Jackson, R. et al. Prediction of Type 1 Diabetes in First-Degree Relatives Using a Combination of Insulin, GAD, and ICA512bdc/IA-2 Autoantibodies. Diabetes Care 1996; 45: 926-933.
4. Bingley, P.J., Bonifacio, B., Williams, A.J.K., Genovese, S., Bottazzo, G.F. and Gale, E.A.M. Prediction of IDDM in the General Population, Strategies Based on Combinations of Autoantibody Markers. Diabetes 1997; 46: 1701-1710.
5. Keller, R.J., Eisenbarth, G.S. and Jackson, R.A. Insulin prohpylaxis in individuals at high risk of type 1 diabetes. Lancet 1993; 341: 927-928.
6. Elliott, R.B., Pilcher, C.C. and Stewart, A. The use of nicotinamide in the prevention of type 1 diabetes. Ann. NY Acad. Sci. 1993; 69: 333-341.
7. Akerblom, H.K., Paganus, A., Teramo, K., Saukkonen, T., Knip, M., Ilonen, J. et al. Primary prevention of type 1 diabetes by nutritional intervention. Description of a pilot study. Autoimmunity 1993; 15: (suppl.): 58.
8. Morrison, A.S., Screening in Chronic Disease. New York: Oxford University Press, 1992.
9. Bach, J., Predictive Medicine: From Molecular Genetics to Prevention, Application to Insulin-Dependent Diabetes Mellitus. Isr. J. Med. Sci. 1992; 28: 111-112.
10. British Diabetic Association. Ethical Issues in Research into Prevention of Insulin-dependent Diabetes Mellitus (IDDM). Diabetic Medicine 1996; 13: 399-400.
11. Nordenfelt, L. Prevention and Ethics in Medicine: The Case of Diabetes Prevention. Journal of Pediatric Endocrinology & Metabolism 1996; 9: 381-386.
12. Dahlquist, G., Blom, L., Tuvemo, T., Nystrom, L., Sandstrom, A. and Wall, S. The Swedish Childhood Diabetes Study - results from a 9-year case register and a 1-year case-referent study indicating that Type 1 (insulin-dependent) diabetes mellitus is associated with both Type 2 (non-insulin dependent) diabetes mellitus and autoimmune disorders. Diabetologia 1989; 32: 2-6.
13. Cudworth, A.G. and Woodrow, J.C., Evidence for HLA-linked genes in "juvenile" diabetes mellitus. BMJ 1975; 3: 133-135.
14. Owerbach, D. and Nerup, J. Restriction fragment length polymorphism of the insulin gene in diabetes mellitus. Diabetes 1982; 31: 275-277.
15. Todd, J.A., Bell, J.I. and McDevitt, H.O. HLA-DQB genes conribute to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987; 329: 599-604.
16. Horn, G., Bugawan, T., Long, C. and Erlich, H., Allelic sequence variation of the HLA-DQ loci: relationship to serology and insulin-dependent diabetes susceptibility. Proc. Natl. Acad. Sci. USA 1988; 85: 602-6016.
17. Erlich, H., Bugawan, T.L., Scharf, S., Nepom, G.T., Tait, B. and Griffith, R.L. HLA-DQB sequence polymorphism and genetic susceptibility to IDDM. Diabetes 1990; 39: 96-103.
18. Field, L.L., Tobias, R. and Magnus, T. A locus on chromosome 15q26 (IDDM3) produces susceptibility to IDDM. Nature Genetics 1994; 8: 189-194.
19. Davies, J.L., Kawaguchi, Y., Bennett, S.T., Copeman, J.B., Cordell, H.J., Pritchard, L.E. et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994; 371: 130-136.
20. Owerbach, D. and Gabbay, K.H. The HOXD8 locues (2q31) is linked to type 1 diabetes: interaction with chromosomes 6 and 11 disease susceptibility genes. Diabetes 1995; 44: 132-136.
21. Hashimoto, L., Habita, C., Beressi, J.P., Delepine, M., Besse, C., Cambon-Thomsen, A. et al. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature 1994; 371: 161-164.
22. Ronningen, K.S., Spurkland, A. and Tait, B.D. HLA class II association in insulin-dependent diabetes mellitus among Blacks, Caucasoids and Japanese. In: Tsui, K., Aizawa, M., Sasazuki T eds. HLA. Vol 1. Oxford: Oxford University Press. 1991; 713-722.
23. Owerbach, D. and Gabbay, K.H. Localization of a type 1 diabetes susceptibility locus to the variable tandem repeat region flanking the insulin gene. Diabetes 1993; 42: 1708-714.
24. Bergholdt, R., Karlsen, A., Johannsen, J., Hansen, P.M., Dinarello, C.A., Nerup, J. et al. Characterization of polymorphism of an interleukin 1 receptor type 1 gene (IL1R1) promoter region (P2) and their relation to insulin-dependent diabetes mellitus (IDDM). Cytokine 1995; 7: 727-733.
25. Copeman, J.B., Cucca, F., Heame, C.M., Cornall, R.J., Reed, P.W., Ronningen, K.S. et al. Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nature Genetics 1995; 9: 80-85.
26. Luo, D., Bui, M.M., Muir, A., Maclaren, N.K., Thomson, G. and She, J. Affected-sib-pair mapping of a novel susceptibility gene to insulin-dependent diabetes mellitus (IDDM8) on chromosome 6q25-q27. Am. J. Hum. Genet. 1995; 57: 911-919.
27. Field, L.L., Tobias, R., Thomson, G. and Plon, S. Susceptibility to insulin-dependent diabetes mellitus maps to a locus (IDDM11) on chromosome 14q24.3-q31. Genomics 1996; 33: 1-8.
28. Morahan, G., Huang, D., Tait, B.D., Colman, P.G. and Harrison, L.C. Markers on distal chromosome 2q linked to insulin-dependent diabetes mellitus. Science 1996; 272: 1811-1813.
29. Erlich, H., Griffith, R.L., Bugawan, T.L., Ziegler, R., Alper, C. and Eisenbarth, G.S. Implication of specific DQB1 alleles in genetic susceptibility and resistance by identification of IDDM siblings with novel HLADQB1 allele and unusual DR2 and DR1 haplotypes. Diabetes 1991; 40: 478-481.
30. Pugliese, A., Gianani, R., Moromisato, R., Awdeh, Z.L., Alper, C.A., Erlich, H.A. et al. HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody positive first degree relatives of patients with insulin-dependent diabetes. Diabetes 1995; 44: 608-613.
31. Olmos, P., A'Hem, R., Heaton, D.A., Millward, B.A., Risley, D., Pyke, D.A. and Leslie, R.D.G. The significance of the concordance reate for type 1 (insulin-dependent) diabetes in identical twins. Diabetologia 1988; 31: 747-750.
32. Nistico, L., Buzzetti, R., Pritchard, L.E., Van der Auwera, B., Giovannini, C., Bosi, B. et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Human Molecular Genetics 1996; 5: 1075-1080.
33. Awata, T., Kurihara, S., Iitaka, M., Takei, S., Inoue, I., Ishii, C. et al. Association of CTLA-4 gene A-G polymorephism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' Disease and Hashimoto's Thyroiditis) in the Japanese population. Diabetes 1998; 47: 128-129.
34. Halminen, M., Veijola, R., Reijonen, H., Ilonen, J., Akerblom, H.K., Knip, M. et al. Effect of polymorphism in the insulin gene region on IDDM susceptibility and insulin secretion. Journal of Clinical Investigation 1996; 26: 847-852.
35. Todd, J.A. and Farrall, M. Panning for gold: genome-wide scanning for linkage in type 1 diabetes. Human Molecular Genetics 1996; 5: 1443-1448.
36. Kawaguchi, Y., Ikegami, H., Shen, G.Q., Nakagawa, Y., Fujisawa, T., Hamada, Y. et al. Insulin gene region contributes to genetic susceptibility to, but may to low incidence of, Insulin-Dependent Diabetes Mellitus in Japanese. Biochemical and Biophysical Research Communications 1997; 233: 283-287.
37. Marron, M.P., Raffel, L.J.., Garchon, H.J., Jacob, C.O., Seffano-Rios, M., Martinez Larrad, M.T. et al. Insulin-dependent diabetes mellitus (IDDM) is associated with CTL4 polymorphisms in multiple ethnic groups. Human Molecular Genetics 1997; 6: 1275-1282.
38. Undelien, D.E., Friede, T., Rammensee, H.G., Joner, G., Dahl-Jorgensen, K., Sovik, O. et al. HLA-encoded genetic predisposition in IDDM DR4 subtypes may be associated with different degrees of protection. Diabetes 1997; 46: 143-149.
39. Nejentsev, S., Reijonen, H., Adojaan, B., Kovalchuk, L., Sochnevs, A., Schwartz, E.I. et al. The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302. Diabetes 1997; 46: 1888-1892.
40. Harfouch-Hammoud, E., Timsit, J., Boitard, C., Bach, J.F. and Caillat-Zucman, S. Contribution of DRB1*04 variants to predisposition to or protection from insulin dependent diabetes mellitus is independent of DQ. Journal of Autoimmunity 1996; 9: 411-414.
41. Matsumoto, C., Awata, T., Iwamoto, Y., Kuzuya, T., Saito, T. and Kanazawa, Y. Lack of association of the insulin gene region with Type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 1994; 37: 210-213.
42. Undlien, D.E., Hamaguchi, K., Kimura, A., Tuomilehto, B., Swai, A.B.M., McLarty, D.G. et al. IDDM susceptibility associated with polymorphisms in the insulin gene region; A study of blacks, Caucasians and orientals. Diabetologia 1994; 37: 745-749.
43. Undlien, D.E., Bennett, ST., Todd, J.A., Akselsen, H.E., Ikaheimo, I., Reijonen, H. et al. Insulin gene region-encoded susceptibility to IDDM maps upstream of the insulin gene. Diabetes 1995; 44: 620-625.
44. Van Der Auwera, B., Schuit, F., Lyaruu, I., Falomi, A., Scanhold, S., Vandewalle et al. Genetic Susceptibility for Insulin-Dependent Diabetes Mellitus in Caucasians Revisited: The Importance of Diabetes Registries in Disclosing Interactions between HLA-DQ- and Insulin Gene-Linked Risk. Journal of Clinical Endocrinology and Metabolism 1995; 80(9): 2567-2573.
45. Atkinson, M.A. and Maclaren, N.K. Islet cell autoantigens in insulin-dependent diabetes. J. Clin. Invest. 1993; 92: 1608-1616.
46. Guaita, G., Mulas, M.F., Saba, M., Pelligra, I., Cocco, S., Cossu, B. et al. The Sardinian newborn IDDM (SNI) study. Prevelenee of ICA in a large cohort of 4755 newly born children in Sardinia. Autoimmunity 1995; 21: 38-39.
47. Roll, U., Christie, M.R., Fuchtenbusch, M., Payton, M.A., Hawkes, C.J. and Ziegler, A.G. The German multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood. Diabetes 1996; 45: 967-973.
48. Arvilommi, P., Hakala, R., Kupila, A., Muona, P., Simell, T., Torma, M. et al. ICA-Positive children in the DIPP trial. Diabetes Abstract Book 58th Scientific Sessions June 1998; A227.
49. Yu, M.S., Mitchell, C.M., Butler-Simon, N., Groshek, M., Follensbee, D., Erlich, H. et al. The Impact on Maternal Parenting Stress of Receipt of Genetic Information Regarding Risk of Diabetes in Newborns. Unpublished 1997.
50. Frost, N. Genetic Diagnosis and Treatment. AJDC 1993; 147: 1190-1195.
51. Wingrove, K., Hagerman, R., Barton, P.L. and Norris, J. Experiences and Attitudes Concerning Genetic Testing and Insurance in a Colorado Population: A Survey of Families with Fragile X Syndrome. Unpublished 1996.
52. Atkinson, M.A. and Maclaren, N.K. The pathogenesis of insulin-dependent diabetes mellitus N. Engl. J. Med. 1993; 331: 142-1436.
53. Bach, J.F. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 1994; 15: 516-541.
54. Cudworth, A.G. and Woodrow, J.C. Genetic susceptibility in diabetes mellitus: Analysis of the HLA association. BMJ 1976; 2: 846.
55. Sperling, M.A. Diabetes mellitus. In: Sperling, M.A. ed. Pediatric Endocrinology. Philadelphia: W. B. Saunders. 1996; 229-263.
56. Eisenbarth, G. Prediction and Prevention Strategies in Type 1 Diabetes. The Mount Sinai Journal of Medicine 1991; 58: 274-279.
57. Verge, C. F. and Eisenbarth, G.C. Stragegies for Preventing Type 1 Diabetes Mellitus. West. J. Med. 1996; 164: 249-255.
58. Sorenson, J.R., Levy, H.L., Mangione, T.W. and Sepe, S.J. Parental response to repeat testing of infants with 'false positive' results in a newborn screening program. Pediatrics 1984; 73: 183-187.
59. Johnson, S.B. and Tercyak, K.P. Psychological Impact of Islet Cell Antibody Screeing for IDDM on Children, Adults and their Famiy Members. Diabetes Care 1995; 18: 1370-1372.
60. Dittler, J., Seidel, D., Schenker, M. and Ziegler, A.G. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives. Diabetes 1998; 47: 592-597.
61. Yu, L., Simone, E. and Eisenbarth, G.S. Modification to combined GAD65/ICA512 radioassay for general population screening. Abstract presented at the American Diabetes Association 31st Research Symposium on the Prevention of Type 1 Diabetes in the General Population, Estes Park, September 1996.
62. Vardi, P., Crisa, L. and Jackson, R.A. Predictive calue of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type I (insulin-dependent) diabetic patients. Diabetologia 1991; 34: 93-102.
63. Jackson, R.A. Dual parameter linear model for prediction of onset of type 1 diabetes in islet cell antibody positive relatives. Clin. Res. 1988; 36: 484A.
64. Vlahos, W.D., Seemayer, T.A. and Yale, J.F. Diabetes prevention in BB rates by inhibition of endogenous insulin secretion. Metabolism 1991; 40: 825-829.
65. Atkinson, M.A., Maclaren, N.K. and Luchetta, R. Insulitis and insulin dependent diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 1990; 39: 933-937.
66. Gladstone, P. and Nepon, G.T. The prevention of IDDM: injeting insulin into the cytokine network. Diabetes 1995; 44: 859-862.
67. Aaen, K., Rygard, J., Josenson, K., Brogren, C.H., Horn, T. and Buschard, K. Dependence of antigen expression on functional state of cells. Diabetes 1990; 39: 697-701.
68. Bowman, M.A., Campbell, L. and Darrow, B.L. Immunological and metabolic effects of prophylactic insulin therapy in the NOD-scid/scid adoptive transfer model of IDDM. Diabetes 1996; 45: 205-208.
69. Skyler, J. Presented on behalf of DPTI at ADA meeting. Unpublished 1997.
70. Honeyman, M., Wasserfall, C., Nerup, J. and Rossini, A. Prediction and prevention of IDDM. Diabetologia 1997; 40:
71. Bingley, P. Personal communication, February 1998.
72. Elliott, R.B. and Chase, H.P. Prevention or delay of type 1 (insulin-dependent) diabetes in children using nicotinamide. Diabetologia 1991; 34: 362-366.
73. Elliott, R.B., Pilcher, Fergusson, D.M. and Stewart, A.W. A population based strategy to prevent insulin-dependent diabetes using nicotinamide. J. Pediatr. Endocrinol. Metab. 1996; 9: 501-509.
74. Zhang, I., Davidson, L., Eisenbarth, G. and Weiner, H.L. Suppression of diabetes in non-obese diabetic mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. 1991; 88: 10252-10256.
75. Elliott, J.F., Qin, H.Y., Bhatti, S., Smith, D.K., Singh, R.K., Dillion, T. et al. Immunization with the largerisoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes 1994; 43: 1494-1499.
76. Pozzilli, P. Prevention of insulin-dependent diabetes mellitus 1998. Submitted for publication December 1997.
77. Leslie, R.D.G. and Elliott, R.B., Early environmental events as a cause of IDDM: Evidence and implications. Diabetes 1994; 43: 843-850.
78. Gerstein, H.C. Cow's milk exposure and type 1 diabetes mellitus. A critical overview of the clinical literature. Diabetes Care 1994; 17: 13-19.
79. Norris, J.M. and Scott, F.W. A meta-analysis of infant diet and insulin-dependent diabetes mellitus: do biases play a role? Epidemiology 1996; 7: 87-92.
80. Norris, J.M., Beaty, B., Kligensmith, G., Yu Liping, , Hoffman, M., Chase, H.P. et al. Lack of association between early exposure to cow's milk protein and beta-cell autoimmunity. Diabetes Autoimmunity Study in the Young (DAISY). JAMA 1996; 276: 609-614.
81. Bodington, M., McNally, P.G. and Burden, A.C. Cow's milk and type 1 childhood diabetes: no increase in risk. Diabetic Med. 1994; 11: 662-665.
82. Perez-Bravo, F., Carrasco, B., Gutierrez-Lopez, M.D., Martinez. M.T., Lopez, G., Garcia de los Rios, M. Genetic predisposition and enviornmental factors leading to the development of insulin-dependent diabetes mellitus in Chilean children. Journal of Molecular Medicine 1996; 74: 105-109.
83. Vaarala, O., Klemeti, P., Savilahti, E., Reijonen, H., Ilonen, J. and Akerblom, H.K., Cellular immune response to cow's milk B-lactoglobulin in patients with newly diagnosed IDDM. Diabetes 1996; 45: 178-182.
84. Meloni, T., Marinaro, A.M., Mannazzu, M.C., Ogana, A., La Vecchia, C., Negro, B. et al. IDDM and early infant feeding; Sardinian case-control study. Diabetes Care 1997; 20: 340-342.
85. Marlikainen, A., Saukkonen, T., Kulmala, P.K., Reijonen, H., Ilonen,. Teramo, K. et al. Disease-associated antibodies in offspring of mothers with IDDM. Diabetes 1996; 45: 1706-1710.
86. Levy-Marchal, C., Karjalainen, J., Dubois, F., Karges, W., Czernichow, P. and Dosch, H.M. Antibodies against bovine albumin and other diabetes markers in French children. Diabetes Care 1995; 18: 1089-1094.
87. Karjalainen, J., Martin, J.M., Knip, M., Ilonen, J., Robinson, B.H., Savilahti, E. et al. A bovine albumin peptide as a possible trigger of insulin-dependent diabets mellitus. New England Journal of Medicine 1992; 327: 302-307.
88. Cavallo, M.G., Monetini, L., Barone, F. and Pozzilli, P. Cell mediated immune response to beta caesin in recent onset insulin-dependent diabetes: implications for disease pathogenesis. Lancet 1996; 348: 926-928.
89. Atkinson, M.A., Bowman, M.A., Kao, K.J., Campbell, L., Dush, P.J., Shah, S.C. et al. Laco of immune responsiveness to bovine serum albumin in insulin dependent diabetes. New England Journal of Medicine 1993; 329: 1853-1858.
90. Daniel, D. and Wegnann, D. R. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc. Natl. Acad. Sci. 1996; 93: 956-960.
91. Bowman, M.A., Leiter, E.H. and Atkinson, M.A. Prevention of diabetes in the NOD mouse: implications for theraputic intervention in human disease. Immunology Today 1994; 15: 115-121.